Cannabis alcohol co-use driving risk is no longer theoretical, it is now clearly demonstrated in a controlled clinical trial. This Johns Hopkins RCT shows that combining edibles with alcohol impairs driving more than either substance alone, even below legal alcohol limits. For patients, clinicians, and policymakers, this reframes how we think about impairment and safety in real-world use
Cannabis Edibles and Alcohol Combined Make Driving More Dangerous Than Either Alone, Johns Hopkins RCT Finds
Cannabis alcohol co-use driving risk is no longer theoretical, it is now clearly demonstrated in a controlled clinical trial. This Johns Hopkins RCT shows that combining edibles with alcohol impairs driving more than either substance alone, even below legal alcohol limits. For patients, clinicians, and policymakers, this reframes how we think about impairment and safety in real-world use.
Drugs detected in suspected pediatric exposures: a 5-year review.
A 5-year hospital study found pediatric cannabis exposure emergency department detection patterns showing cannabis metabolites among the most frequently identified compounds in children presenting with suspected toxic ingestions. This surveillance data helps inform clinical testing strategies while highlighting the importance of secure household cannabis storage practices.
Hidden nicotine: Cotinine levels among young adult Black men who smoke cannabis blunts.
A new study reveals that over half of young adults using cannabis blunts have measurable nicotine exposure despite reporting no tobacco use. This research highlights the hidden nicotine exposure cannabis blunts may contain and its clinical implications for patient counseling and addiction risk assessment.
Neurologic Complications of Drug and Alcohol Use.
A comprehensive clinical review identifies emerging neurologic complications across substance classes, with particular attention to potential cannabis-stroke associations. The review provides neurologists with systematic approaches for recognizing substance-related neurologic syndromes and highlights the need for updated clinical vigilance as drug supplies and legalization patterns evolve.
Association of Multimodal Cannabis Use with Adverse Events among Adolescents and Young Adults.
The ways cannabis is consumed, or modes of use, have increased and diversified in recent years, especially among young people. Associations of multimodal can…
Implementation of a Standardized Management Algorithm for Cannabis Hyperemesis Syndrome in a Pediatric Emergency Department.
Cannabis hyperemesis syndrome (CHS) is an increasingly common cause of pediatric emergency department (ED) visits, yet management pathways remain understudie…
Mobile app-based study of driving behaviors under the influence of cannabis.
A small study of 9 participants found correlations between cannabis use and altered driving behaviors using cannabis driving impairment smartphone detection technology. The research demonstrates feasibility of real-world monitoring but requires larger validation studies before clinical application.
The quality and scope of health information on online drug platforms: a topic modelling and expert evaluation study of a Polish-language forum.
Determining health information quality on online drug platforms is crucial for revealing and shaping substance use practices. The study aims to assess the sc…
Acute toxicity of ADB-CHMINACA – a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome.
A new case series reveals that synthetic cannabinoid toxicity emergency treatment protocols are urgently needed as ADB-CHMINACA causes rapid-onset seizures and encephalopathy. Emergency physicians document severe neurologic complications occurring within minutes of synthetic cannabinoid use, highlighting critical safety differences from natural cannabis.